These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 7578902

  • 1. Differential effects of staphylokinase, streptokinase and tissue-type plasminogen activator on the lysis of retracted human plasma clots and fibrinolytic plasma parameters in vitro.
    Hauptmann J, Glusa E.
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):579-83. PubMed ID: 7578902
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
    Collen D, Van Hoef B, Schlott B, Hartmann M, Gührs KH, Lijnen HR.
    Eur J Biochem; 1993 Aug 15; 216(1):307-14. PubMed ID: 7689966
    [Abstract] [Full Text] [Related]

  • 3. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M, Lijnen HR, Keber D, Collen D.
    Thromb Haemost; 1989 Dec 29; 62(4):1083-7. PubMed ID: 2515603
    [Abstract] [Full Text] [Related]

  • 4. Synergy of in vitro thrombolytic action of combinations of recombinant staphylokinase and single-chain urokinase-type plasminogen activator.
    Aisina RB, Moukhametova LI, Varfolomeyev SD.
    Biochemistry (Mosc); 2003 Nov 29; 68(11):1252-60. PubMed ID: 14640969
    [Abstract] [Full Text] [Related]

  • 5. Fibrin-specific fibrinolysis induced by recombinant staphylokinase.
    Shishido Y, Matsumoto T, Sakai M, Kaneda N, Sansawa H, Shimura K, Hashimoto S, Yokokura T.
    Biol Pharm Bull; 1994 Aug 29; 17(8):1060-4. PubMed ID: 7820108
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.
    Andrew M, Brooker L, Leaker M, Paes B, Weitz J.
    Thromb Haemost; 1992 Sep 07; 68(3):325-30. PubMed ID: 1440499
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of tissue plasminogen activator, streptokinase, and staphylokinase on cerebral ischemic infarction and pulmonary clot lysis in hamster models.
    Nagai N, Vanlinthout I, Collen D.
    Circulation; 1992 Sep 07; 100(25):2541-6. PubMed ID: 10604893
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
    Sakai M, Watanuki M, Matsuo O.
    Biochem Biophys Res Commun; 1989 Jul 31; 162(2):830-7. PubMed ID: 2527034
    [Abstract] [Full Text] [Related]

  • 14. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.
    Silence K, Collen D, Lijnen HR.
    Blood; 1993 Aug 15; 82(4):1175-83. PubMed ID: 7688990
    [Abstract] [Full Text] [Related]

  • 15. Comparative immunogenicity and thrombolytic properties toward arterial and venous thrombi of streptokinase and recombinant staphylokinase in baboons.
    Collen D, De Cock F, Stassen JM.
    Circulation; 1993 Mar 15; 87(3):996-1006. PubMed ID: 8443918
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential.
    Onundarson PT, Francis CW, Marder VJ.
    J Lab Clin Med; 1992 Jul 15; 120(1):120-8. PubMed ID: 1613318
    [Abstract] [Full Text] [Related]

  • 19. [Streptokinase and Staphylokinase: Differences in the Kinetics and Mechanism of Their Interaction with Plasminogen, Inhibitors and Fibrin].
    Aisina RB, Mukhametova LI, Gulin DA, Gershkovich KB, Varfolomeyev SD.
    Bioorg Khim; 2015 Jul 15; 41(5):565-78. PubMed ID: 26762094
    [Abstract] [Full Text] [Related]

  • 20. Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitro.
    Samama M, Nguyen G, Desnoyers P, Lourenco DM, Fretault J, Horellou MH, Conard J, Szwarcer E, Verdy E, Vahanian A.
    Fundam Clin Pharmacol; 1988 Jul 15; 2(6):509-23. PubMed ID: 3149257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.